Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Moxifloxacin Impurity H

Moxifloxacin Impurity H is listed in the pharmaceutical impurity collection under CAS 147459-51-6. Its represented structure has formula C7H14N2 and a calculated molecular weight of 126.20 g/mol.

2D chemical structure

N H H N H H ( R ) ( R )

Chemical identity

Catalog name
Moxifloxacin Impurity H
Common name
Moxifloxacin Impurity H
Chemical name
(4aR,7aR)-2,3,4,4a,5,6,7,7a-octahydro-1H-pyrrolo[3,4-b]pyridine
CAS
147459-51-6
SMILES
C1CN[C@H]2CNC[C@H]2C1
InChI
InChI=1S/C7H14N2/c1-2-6-4-8-5-7(6)9-3-1/h6-9H,1-5H2/t6-,7+/m1/s1
InChIKey
KSCPLKVBWDOSAI-RQJHMYQMSA-N
Associated API
Moxifloxacin

Record ID: A1672e3206f7b

Computed properties

C7H14N2 Molecular formula
126.203 g/molMolecular weight
126.1157 DaMonoisotopic exact mass
24.06 ŲTopological polar surface area
-0.0422 Calculated LogP (Wildman–Crippen)
37.3844 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight126.2032.66
Calculated LogP (Wildman–Crippen)-0.042213.71
Topological polar surface area24.068.94
Hydrogen-bond acceptors215.92
Hydrogen-bond donors264.87
Rotatable bonds (strict)03.45

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC7H14N2dimensionless
Molecular weight126.203g/mol
Monoisotopic exact mass126.1157Da
Topological polar surface area24.06Ų
Calculated LogP (Wildman–Crippen)-0.0422dimensionless
Molar refractivity (Wildman–Crippen)37.3844cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors2count
Rotatable bonds (strict)0count
Heavy atoms9count
Heteroatoms2count
Rings2count
Aromatic rings0count
Aliphatic rings2count
Saturated rings2count
Aromatic heterocycles0count
Aliphatic heterocycles2count
Saturated heterocycles2count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms1fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area56.017Ų
Valence electrons52count
Radical electrons0count
Bertz complexity91.0893index
Balaban J1.9698index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Moxifloxacin Impurity H

Qualification and safety assessment of Moxifloxacin Impurity H

Explore toxicological qualification of Moxifloxacin Impurity H and ICH M7 mutagenic impurity assessment of Moxifloxacin Impurity H for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Moxifloxacin Impurity H and acceptable intake and limit justification for Moxifloxacin Impurity H. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Moxifloxacin Impurity H

Explore Altox services and software through the Altox Pharma-Hub.